Article - 19/03/2012 Quantification of the morphology of human blood vessels from 3D tomographic image data “QuantVessel”, an innovative approach designed to accurately determine the size and shape of blood vessels from 3D tomographic images, enables vascular diseases to be diagnosed more reliably and makes surgery more effective. The project is being carried out by researchers from the BioQuant centre at Universität Heidelberg and Deutsches Krebsforschungszentrum (German Cancer Research Center) and funded by the German Research Foundation (DFG). It…https://www.gesundheitsindustrie-bw.de/en/article/news/quantification-of-the-morphology-of-human-blood-vessels-from-3d-tomographic-image-data
Article - 12/03/2012 Q-bios provides client-specific biotechnology services Q-bios GmbH, a spin-off from the Mannheim University of Applied Sciences, is a biotechnology company that provides services related to the production and purification of diagnostic and therapeutic proteins as well as the development and amplification of suitable cell lines. The company offers its services, which are based on state-of-the-art technologies, to clients from the biotechnology, diagnostic and pharmaceutical industries.https://www.gesundheitsindustrie-bw.de/en/article/news/q-bios-provides-client-specific-biotechnology-services
Article - 06/02/2012 Ten outstanding ideas in biotechnology and medical technology The results of the feasibility studies funded under the Idea Competition in Biotechnology and Medical Technology were presented in the Haus der Wirtschaft in Stuttgart between 16th and 18th January 2012. Ten of the 42 project ideas were recommended for further funding.https://www.gesundheitsindustrie-bw.de/en/article/news/ten-outstanding-ideas-in-biotechnology-and-medical-technology
Press release - 09/01/2012 EU: "Virtual liver" technology helps detect liver tumours Scientists and surgeons from France, Germany, United Kingdom and Switzerland have developed a "virtual liver", using EU research funding, which will help surgeons better plan and carry out tumour operations and ensure quicker patient recovery. The PASSPORT project (Patient-Specific Simulation and Pre-Operative Realistic Training) makes a uniquely accurate "virtual liver" available to physicians based on medical images sent by…https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-virtual-liver-technology-helps-detect-liver-tumours
Press release - 19/12/2011 cetics healthcare - Metabolomic snapshot – one drop blood is enough Newly founded Esslingen-based cetics healthcare technologies is developing a new platform that combines innovative analysis technologies for medical diagnostics. By linking biological testing methods with spectroscopic detection technology and automation, information on all key blood values and existing medical conditions can be delivered in just one single measurement.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cetics-healthcare-metabolomic-snapshot-one-drop-blood-is-enough
Article - 19/12/2011 Lenhard Rudolph prepares four biomarkers for clinical application Lenhard Rudolph’s biomarker quartet is extremely promising in terms of progressing medical and clinical treatment in ageing societies. The quartet - EF-1 alpha, Chi3L3, CRAMP and OP 18 – is made up of four proteins that can potentially be used as biomarkers. Specific concentrations of these molecules in human blood provide information on the biological age and renewal capacity of the tissue and organs of patients. The biomarker quartet also…https://www.gesundheitsindustrie-bw.de/en/article/news/lenhard-rudolph-prepares-four-biomarkers-for-clinical-application
Press release - 17/12/2011 Rapid identification of blood poisoning Does the patient have blood poisoning? In order to find out, the doctor takes a blood sample and sends it to a central laboratory for testing. Valuable time is lost, which could cost the patient his or her life. In future, doctors will be able to analyse blood in their surgery and results will be available within twenty minutes. This is made possible by a biochip developed by scientists at the Fraunhofer Institute for Physical Measurement…https://www.gesundheitsindustrie-bw.de/en/article/press-release/rapid-identification-of-blood-poisoning
Article - 12/12/2011 Rheumatoid arthritis biomarkers A plethora of biomarkers is available for the early diagnosis of rheumatoid arthritis and associated tissue damage and disorders. In addition, new biomarkers that improve the diagnosis and treatment of patients suffering from this common destructive autoimmune disease are constantly being discovered.https://www.gesundheitsindustrie-bw.de/en/article/news/rheumatoid-arthritis-biomarkers
Article - 12/12/2011 The detection of inflammation in “single-use laboratories“ Depression, rheumatism, sickle cell anaemia – elevated levels of substance P in blood plasma might be an alarm signal. The molecule plays an important role in generating an inflammatory response. Commercially available tests involving microtitre plates are time-consuming and expensive. Dr. Hüseyin Bakirci and his team from the Department of Microsystems Engineering (IMTEK) at the University of Freiburg have developed a chip the size of a…https://www.gesundheitsindustrie-bw.de/en/article/news/the-detection-of-inflammation-in-single-use-laboratories
Article - 12/12/2011 Comprehensive Biomarker Center GmbH – next-generation biomarkers Biomarker research has moved on from proteins to nucleic acids where one of the main priorities is the use of microRNA expression profiles. The Heidelberg-based biotech company Comprehensive Biomarker Center GmbH (CBC, formerly febit) has state-of-the-art technologies and the skills and knowledge to advance the development of new nucleic acid biomarkers for complex diseases in cooperation with partners from research and industry. https://www.gesundheitsindustrie-bw.de/en/article/news/comprehensive-biomarker-center-gmbh-next-generation-biomarkers
Dossier - 12/12/2011 Development of new molecular biomarkers Biomarkers are playing an increasing role in drug discovery and development. They can be used as molecular indicators for diseases and disease risks as well as for monitoring the effectiveness of therapy. Highly specific molecular biomarkers are being identified using state-of-the-art technologies from the fields of genomics, proteomics and metabolomics.https://www.gesundheitsindustrie-bw.de/en/article/dossier/development-of-new-molecular-biomarkers
Article - 28/11/2011 Dogs – the latest way to detect lung cancer Dogs can reliably sniff out lung cancer, according to a study carried out by a group of doctors from Stuttgart. The study shows that a dog can accurately detect cancer-specific components by sniffing human breath.https://www.gesundheitsindustrie-bw.de/en/article/news/dogs-the-latest-way-to-detect-lung-cancer
Press release - 03/11/2011 Curetis AG attracts Forbion and Roche as new investors Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, announced the expansion of its Series A financing round by € 9.6 million. The additional funds increase the round to a total of € 34.1 million and the total capital raised to date to € 36.6 million. https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-attracts-forbion-and-roche-as-new-investors
Article - 24/10/2011 BioValley Meet & Match Microfluidics, Lab-on-a-chip This year's third Meet & Match took place at the Novotel in Karlsruhe, Germany on October 20, 2011. About 12 presentations were held by representatives from different companies and universities out of the trinational BioValley: Northwest Switzerland, Alsace in France and South Baden in Germany. This Meet & Match meeting has been a great success thanks to interesting talks and a very attentive audience.https://www.gesundheitsindustrie-bw.de/en/article/news/biovalley-meet-match-microfluidics-lab-on-a-chip
Press release - 24/10/2011 Curetis AG Opens Unyvero™ Cartridge Production Facility Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, announced the opening of its state-of-the-art production facility for disposable Unyvero™ cartridges in Bodelshausen (near Tuebingen, Germany).https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-opens-unyvero-cartridge-production-facility
Article - 17/10/2011 “The only way of keeping competition in the international market at bay” Biotech companies operate mostly on a global level. This is either because they follow their customers or because their major markets are abroad or because their domestic markets are so small that they are obliged to market their products abroad. Patents do not play a key role in all industries, but are of decisive strategic importance in the biotechnology sector. "However, patents are not always the best," says Ulrike Cremer, a patent…https://www.gesundheitsindustrie-bw.de/en/article/news/the-only-way-of-keeping-competition-in-the-international-market-at-bay
Press release - 05/09/2011 Sequenom announces European licensing agreement with GATC daughter LifeCodexx Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test…https://www.gesundheitsindustrie-bw.de/en/article/press-release/sequenom-announces-european-licensing-agreement-with-gatc-daughter-lifecodexx
Article - 29/07/2011 Labor Dr. Merk und Kollegen - Viruses under control It is difficult to imagine how Ochsenhausen-based Labor Dr. Merk und Kollegen (LMK) would be able to develop, produce and test medical products for bacterial and viral contaminations without using cell cultures. The medium-sized company also produces viruses for testing and has stored more than 80 different viruses – enveloped and non-enveloped ones, animal and human pathogens – at -80˚C.https://www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-und-kollegen-viruses-under-control
Press release - 20/07/2011 Roche acquires mtm laboratories AG, expanding offering in cervical cancer Roche announced on July 19th that it has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany. mtm is a global leader in developing in vitro diagnostics with a focus on early detection and diagnosis of cervical cancer, the largest early detection market in oncology. mtm will become part of Roche’s Tissue Diagnostics (Ventana Medical Systems, Inc.) business…https://www.gesundheitsindustrie-bw.de/en/article/press-release/roche-acquires-mtm-laboratories-ag-expanding-offering-in-cervical-cancer
Press release - 15/07/2011 HITS Participates in a new DFG Research Unit on Blood Coagulation Scientists from the Heidelberg Institute for Theoretical Studies participate in a new Research Unit on blood coagulation sponsored by the German Research Foundation (DFG). The aim of the DFG funding is to support a successful existing cooperation between scientists over several years.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hits-participates-in-a-new-dfg-research-unit-on-blood-coagulation
Article - 27/06/2011 The EURAT project at the Marsilius Kolleg in Heidelberg Bioinformaticians, human geneticists, molecular biologists, oncologists, pathologists, lawyers and theologians are all participating in the project “Ethical and legal aspects of the total sequencing of the human genome” (EURAT) being carried out at Heidelberg University’s Marsilius Kolleg. The project partners are developing a common viewpoint and working out solutions for problems arising from the possibilities of total genome sequencing. https://www.gesundheitsindustrie-bw.de/en/article/news/the-eurat-project-at-the-marsilius-kolleg-in-heidelberg
Press release - 08/06/2011 TagCyx Biotechnologies TagCyx is a research based company located in Yokohama Kanagawa Prefecture. The core technologies of TagCyx are unnatural base pair technologies and nucleic acids stabilization technology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tagcyx-biotechnologies
Press release - 01/06/2011 Heidelberg expert to coordinate European network on inherited metabolic disorders A European network for research into rare inherited metabolic disorders will be coordinated by PD Dr. Stefan Kölker, head of the Division of Inherited Metabolic Diseases at the Centre for Paediatric and Adolescent Medicine, University of Heidelberg. The project, which will initially run for three years, has a financial volume of 1.3 million euros. More than 40 partners from 17 European countries are part of the “European registry and network for…https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-expert-to-coordinate-european-network-on-inherited-metabolic-disorders
Article - 30/05/2011 Technology Licensing Office (TLB): invention and patent management The Technology Licensing Office TLB works in partnership with science and industry and is continuously coming up with new ways to ensure the economic success of inventions from all the key fields of technology. Dr. Frank Schlotter head of Life Sciences at the Karlsruhe-based TLB provides insights into the work that his office does taking as examples innovations from the fields of regenerative medicine and diagnostics.https://www.gesundheitsindustrie-bw.de/en/article/news/technology-licensing-office-tlb-invention-and-patent-management
Article - 30/05/2011 From bench to bedside to bench The term translational medicine does not always refer to the concept “from bench to bedside and back”, and indeed is often used to refer to many other, somewhat distant, concepts. However, the new translation centres and translational research consortia do correspond to the original meaning. These new centres and consortia have become effective structures in health research in Germany whose goal is the continuous improvement of the diagnostic and…https://www.gesundheitsindustrie-bw.de/en/article/news/from-bench-to-bedside-to-bench